GAMBICORTI, Elena
 Distribuzione geografica
Continente #
NA - Nord America 1.203
EU - Europa 339
AS - Asia 286
OC - Oceania 3
AF - Africa 1
Totale 1.832
Nazione #
US - Stati Uniti d'America 1.200
CN - Cina 155
UA - Ucraina 124
SG - Singapore 65
DE - Germania 55
HK - Hong Kong 40
IT - Italia 32
FI - Finlandia 31
IE - Irlanda 22
GB - Regno Unito 19
RU - Federazione Russa 19
TR - Turchia 19
CZ - Repubblica Ceca 14
FR - Francia 6
IN - India 6
BE - Belgio 5
NL - Olanda 5
AU - Australia 3
SE - Svezia 3
CA - Canada 2
RO - Romania 2
EE - Estonia 1
HU - Ungheria 1
JP - Giappone 1
MX - Messico 1
SL - Sierra Leone 1
Totale 1.832
Città #
Fairfield 227
Woodbridge 116
Jacksonville 98
Cambridge 94
Seattle 91
Houston 88
Ashburn 85
Wilmington 82
Ann Arbor 70
Singapore 54
Chandler 45
Princeton 42
Hong Kong 40
Beijing 34
Helsinki 27
Nanjing 27
Dublin 21
Istanbul 19
Brno 14
Shanghai 14
New York 12
Des Moines 11
Moscow 11
Shenyang 11
Jinan 9
Munich 9
Nanchang 9
San Diego 9
San Francisco 9
Changsha 7
Falkenstein 7
Jiaxing 7
Tianjin 7
Hebei 6
Brescia 5
Brussels 5
London 5
Milan 5
Orange 5
Dearborn 4
Florence 4
Verona 4
Haikou 3
Hangzhou 3
Kunming 3
Taizhou 3
Zhengzhou 3
Boardman 2
Canberra 2
Lancaster 2
Ningbo 2
Pune 2
Redwood City 2
San Giuliano Terme 2
Toronto 2
Trento 2
Zuid-Beijerland 2
Acton 1
Ascoli Piceno 1
Budapest 1
Castiglione Delle Stiviere 1
Freetown 1
Fuzhou 1
Guangzhou 1
Hefei 1
Jersey City 1
Kilburn 1
Lanzhou 1
Melbourne 1
Prescot 1
Pullach im Isartal 1
Rende 1
Tallinn 1
Totale 1.500
Nome #
ILM peeling in nontractional diabetic macular edema: review and metanalysis 126
Efficacy and vitreous levels of topical NSAIDs 116
Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overview 108
PEELING OF THE INTERNAL LIMITING MEMBRANE WITH FOVEAL SPARING FOR TREATMENT OF DEGENERATIVE LAMELLAR MACULAR HOLE 107
Pharmacokinetic and Pharmacodynamic Properties of Anti-VEGF Drugs After Intravitreal Injection 101
From the analysis of pharmacologic vitreolysis to the comprehension of ocriplasmin safety 100
Controversies over the role of internal limiting membrane peeling during vitrectomy in macular hole surgery 100
Comparison of half-dose photodynamic therapy and 689 nm laser treatment in eyes with chronic central serous chorioretinopathy 100
Aflibercept in wet AMD: specific role and optimal use 99
Heavy silicone oil and intraocular inflammation 99
Heavy and standard silicone oil: intraocular inflammation 96
Central serous chorioretinopathy: Pathogenesis and management 94
Current trends about inner limiting membrane peeling in surgery for epiretinal membranes 93
Combination of ranibizumab and indomethacin for neovascular age-related macular degeneration: randomized controlled trial 89
FOVEA-SPARING VERSUS COMPLETE INTERNAL LIMITING MEMBRANE PEELING IN VITRECTOMY FOR THE TREATMENT OF MACULAR HOLES 86
Functional and Morphological Changes Following Macular Pucker Surgery After Topical Administration of Indomethacin 0.5%, Bromfenac 0.09%, Nepafenac 0.1%, or Placebo 76
Gene expression analysis identifies two distinct molecular clusters of idiopatic epiretinal membranes 73
Epiretinal Membrane Peeling with Foveal Sparing of the Internai Limiting Membrane: A Pilot Study 65
Comparison of visual and anatomical outcomes of half-dose photodynamic therapy and 689 nm laser treatment (pseudo-PDT) in eyes with chronic central serous chorioretinopathy 60
Foveal sparing internal limiting membrane peeling for Lamellar Macular Hole 59
Prospective Randomized Controlled Trial of Combination Ranibizumab and Indomethacin for Neovascular Age-Related Macular Degeneration 55
Vitreous from idiopathic epiretinal membrane patients induces glial-to-mesenchymal transition in Müller cells 14
Totale 1.916
Categoria #
all - tutte 10.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.410


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020332 0 0 0 0 0 53 45 58 58 71 10 37
2020/2021390 4 48 19 38 28 64 37 36 29 43 32 12
2021/2022191 26 17 10 14 1 8 3 18 9 23 14 48
2022/2023141 26 2 6 6 17 32 0 14 25 1 7 5
2023/2024175 15 6 27 8 11 19 7 6 41 3 3 29
2024/2025137 14 0 1 47 37 38 0 0 0 0 0 0
Totale 1.916